This information was published on 2024-11-19T14:27:45 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2269025 (IR 1660214) |
| (220) |
06 Dec 2021
|
| (300) |
US, 12 Nov 2021, 97123120
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Pharmaceuticals; pharmaceuticals for use in the treatment of infectious diseases and disorders and in the field of oncology. Class 42 Research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines. |
| (540) | VIR BIOTECHNOLOGY |
| (550) | Word |
| (730) |
Vir Biotechnology, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.